China sees surge in child infections as hospitals overflow
Chinese doctors have reported a sharp increase in metapneumovirus (hMPV) infections, which national medical authorities have confirmed. According to the Independent, the infection surge primarily affects children under 14 years old and is particularly noticeable in northern China.
Recordings on social media show overwhelmed hospitals, reminiscent of the beginning of the COVID-19 pandemic. Nonetheless, Beijing reassures the public that the rise in infections is typical for winter. Symptoms of the infection include high fever, cough, and sore throat; in some cases, it can lead to bronchitis or pneumonia.
Viruses such as metapneumovirus (hMPV) and concurrent influenza and RSV infections raise epidemiological concerns worldwide. There is no vaccine or specific medication for hMPV, which is already causing numerous hospitalizations due to acute bronchitis.
Viruses like hMPV are known for their tendency to mutate, making it difficult to control and predict the course of the epidemic.
Experts warn that viral infections can lead to severe complications, especially during the fall and winter. The possibility of co-infection with influenza, RSV, and metapneumovirus presents additional challenges for healthcare, as it places a greater burden on the immune system and increases the risk of complications in patients.
Neighboring countries react. WHO has made a decision
Neighboring countries like Hong Kong and India are monitoring the situation. Hong Kong has reported several cases of hMPV, while India has not observed an increase in respiratory illnesses. In Iran, medical authorities reassure the public that there is no cause for concern, and the WHO has not deemed the situation as requiring special action.
The most affected are children and the elderly, who, due to weakened immune systems, are more susceptible to severe illness progression. The rise in hospitalizations due to respiratory illnesses requires healthcare systems to be prepared to meet patient needs and implement new epidemic management strategies.
